STADA Group, established in 1895 and headquartered in Germany, has become a pillar in the Health Care industry. Known for its strong presence in pharmacies, STADA is a trusted name thanks to its century-long commitment to manufacturing high-quality pharmaceuticals. The company focuses on a strategic triad: consumer healthcare products, generics, and specialty pharma, advancing its mission of being a "Caring for People’s Health as a Trusted Partner." Current operations extend to over 100 countries, highlighting its expansive global footprint.
The last significant financial milestone for STADA was a Private Equity Round investment on August 18, 2017, with leading investors such as Nidda Healthcare, Bain Capital Private Equity, Canada Pension Plan Investment Board, and Cinven. This investment aimed to further accelerate its growth trajectory. With its robust product offering and extensive market reach, STADA Group remains a compelling opportunity for investors seeking established and reliable ventures in the pharmaceutical sector.